Preparation and Use of Tumor Antigen from Pathological Immunoglobulinfor Patients with Multiple Myeloma
Authors:
R. Musilová 1; E. Táborská 2; L. Bourková 1; T. Büchler 1,3; L. Hanák 1; L. Kovářová 1,3; H. Novotná 4; M. Penka 1; R. Hájek 1,3
Authors‘ workplace:
Laboratoř experimentální hematologie a buněčné imunoterapie, Oddělení klinické hematologie, FN Brno, 2Lékařská fakulta MU, Katedra lékařské chemie a biochemie, 3Interní hematoonkologická klinika, FN Brno, 4Oddělení klinické biochemie, FN Brno
1
Published in:
Transfuze Hematol. dnes,, 2002, No. 3, p. 0.
Category:
Overview
Idiotype vaccination can be used as immunotherapy for B-cell malignancies, including multiplemyeloma. Malignant plasma cells produce monoclonal immunoglobulin that can be detected in theserum and/or urine and is tumour-specific. To isolate the myeloma Id protein we used affinity chromatographyon a protein G column. Id was eluted with 0.2M glycine-HCl. The protein was more than 90 %pure as determined by SDS-polyacrylamide gel electrophoresis. Id protein was conjugated with KLHin the presence of 0.1% glutaraldehyde. The conjugation product was administered in the preclinicalexperiment to test vaccination as a part of the clinical protocol under preparation.
Key words:
monoclonal immunoglobulin, idiotypic protein, affinity chromatography
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2002 Issue 3
Most read in this issue
- Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) in the Treatment of Non-Hodgkin’sLymphomas. Our Initial Experience
- Iron Overload and its Association with HaematologicalFindings in Porphyria Cutanea Tarda
- Survey of Public Opinion of Non-remunerated Blood Donors
- Preparation and Use of Tumor Antigen from Pathological Immunoglobulinfor Patients with Multiple Myeloma